Rationale and design for the defibrillators to reduce risk by magnetic resonance imaging evaluation (DETERMINE) trial

Journal of Cardiovascular Electrophysiology

Volumn 20, Issue 9, 2009, Pages 982-987

  Kadish, Alan H ^a   Bello, David ^b   Finn, J Paul ^c   Bonow, Robert O ^a   Schaechter, Andi ^a   Subacius, Haris ^a   Albert, Christine ^d   Daubert, James P ^e   Fonseca, Carissa G ^c   Goldberger, Jeffrey J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b ORLANDO REGIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

ICD; MRI; Ventricular tachycardia fibrillation

Indexed keywords

ARTICLE; CINERADIOGRAPHY; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FOLLOW UP; HEART ARREST; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; CORONARY ARTERY DISEASE; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 69249170004     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2009.01503.x     Document Type: Article

References (37)

1. Huikuri HV, Castellanos A, Myerburg RJ : Sudden death due to cardiac arrhythmias. N Engl J Med 2001 345 : 1473 1482.
2. Bolick DR, Hackel DB, Reimer KA, Ideker RE : Quantitative analysis of myocardial infarct structure in patients with ventricular tachycardia. Circulation 1986 74 : 1266 1279.
3. Bayes de Luna A, Coumel P, Leclercq JF : Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989 117 : 151 159.
4. Adhar GC, Larson LW, Bardy GH, Greene HL : Sustained ventricular arrhythmias: Differences between survivors of cardiac arrest and patients with recurrent sustained ventricular tachycardia. J Am Coll Cardiol 1988 12 : 159 165.
5. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M : Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996 335 : 1933 1940.
6. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH : Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 352 : 225 237.
7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G : Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med 1999 341 : 1882 1890.
8. Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB : Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006 113 : 2733 2743.
9. Choudhury L, Mahrholdt H, Wagner A, Choi KM, Elliott MD, Klocke FJ, Bonow RO, Judd RM, Kim RJ : Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002 40 : 2156 2164.
10. Kannel WB, Abbott RD : Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med 1984 311 : 1144 1147.
11. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ : Visualization of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001 357 : 21 28.
12. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, Kadish AH, Goldberger JJ : Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol 2005 45 : 1104 1108.
13. Bello D, Kaushal R, Fieno DS, Radin M, Shaoulian E, Narula J, Goldberger J, Kadish A, Shivkumar K : Cardiac MRI: Infarct size is an independent predictor of mortality in patients with coronary artery disease. J Am Coll Cardiology 2005 45 : 288A.
14. Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M, Kim RJ : Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003 108 : 1945 1953.
15. Wu E, Ortiz JT, Tejedor P, Lee DC, Bucciarelli-Ducci C, Kansal P, Carr JC, Holly TA, Lloyd-Jones D, Klocke FJ, Bonow RO : Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: Prospective cohort study. Heart 2008 94 : 730 736.
16. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM : Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999 100 : 1992 2002.
17. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM : Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000 36 : 1985 1991.
18. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM : An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001 218 : 215 223.
19. Roes SD, Kelle S, Kaandorp TA, Kokocinski T, Poldermans D, Lamb HJ, Boersma E, Van Der Wall EE, Fleck E, de Roos A, Nagel E, Bax JJ : Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007 100 : 930 936.
20. Myerburg RJ, Mitrani R, Interian A Jr., Castellanos A : Interpretation of outcomes of antiarrhythmic clinical trials: Design features and population impact. Circulation 1998 97 : 1514 1521.
21. Al-Khatib SM, Sanders GD, Mark DB, Lee KL, Bardy GH, Bigger JT, Buxton AE, Connolly S, Kadish A, Moss A, Feldman AM, Ellenbogen KA, Singh S, Califf RM : Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: Randomized trial evidence through 2004. Am Heart J 2005 149 : 1020 1034.
22. Yan AT, Shayne AJ, Brown KA, Gupta SN, Chan CW, Luu TM, Di Carli MF, Reynolds HG, Stevenson WG, Kwong RY : Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006 114 : 32 39.
23. Fieno DS, Hillenbrand HB, Rehwald WG, Harris KR, Decker RS, Parker MA, Klocke FJ, Kim RJ, Judd RM : Infarct resorption, compensatory hypertrophy, and differing patterns of ventricular remodeling following myocardial infarctions of varying size. J Am Coll Cardiol 2004 43 : 2124 2131.
24. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE : Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004 43 : 2253 2259.
25. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK : ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004 110 : 588 636. (Pubitemid 39036178)
26. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM : A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006 48 : 330 339.
27. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK : Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008 52 : 541 550.
28. Kacere RD, Pereyra M, Nemeth MA, Muthupillai R, Flamm SD : Quantitative assessment of left ventricular function: Steady-state free precession MR imaging with or without sensitivity encoding. Radiology 2005 235 : 1031 1035.
29. Fieno DS, Jaffe WC, Simonetti OP, Judd RM, Finn JP : TrueFISP: Assessment of accuracy for measurement of left ventricular mass in an animal model. J Magn Reson Imaging 2002 15 : 526 531.
30. Carr JC, Simonetti O, Bundy J, Li D, Pereles S, Finn JP : Cine MR angiography of the heart with segmented true fast imaging with steady-state precession. Radiology 2001 219 : 828 834.
31. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS : Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002 105 : 539 542.
32. Epstein AE, Carlson MD, Fogoros RN, Higgins SL, Venditti FJ Jr. : Classification of death in antiarrhythmia trials. J Am Coll Cardiol 1996 27 : 433 442.
33. Burns JL, Serber ER, Keim S, Sears SF : Measuring patient acceptance of implantable cardiac device therapy: Initial psychometric investigation of the Florida Patient Acceptance Survey. J Cardiovasc Electrophysiol 2005 16 : 384 390.
34. Kuhl EA, Dixit NK, Walker RL, Conti JB, Sears SF : Measurement of patient fears about implantable cardioverter defibrillator shock: An initial evaluation of the Florida Shock Anxiety Scale. Pacing Clin Electrophysiol 2006 29 : 614 618.
35. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML : Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 346 : 877 883.
36. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH : Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004 350 : 2151 2158.
37. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM : Cardiac- resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004 350 : 2140 2150.